These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31720408)

  • 61. Impact of on-site Xpert on TB diagnosis and mortality trends in Uganda.
    Walusimbi S; Najjingo I; Zawedde-Muyanja S; Musaazi J; Nyombi A; Katagira W; Ssendiwala J; Muttamba W
    Public Health Action; 2022 Jun; 12(2):90-95. PubMed ID: 35734005
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Contact tracing versus facility-based screening for active TB case finding in rural South Africa: A pragmatic cluster-randomized trial (Kharitode TB).
    Hanrahan CF; Nonyane BAS; Mmolawa L; West NS; Siwelana T; Lebina L; Martinson N; Dowdy DW
    PLoS Med; 2019 Apr; 16(4):e1002796. PubMed ID: 31039165
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.
    Bates M; Ahmed Y; Chilukutu L; Tembo J; Cheelo B; Sinyangwe S; Kapata N; Maeurer M; O'Grady J; Mwaba P; Zumla A
    Trop Med Int Health; 2013 Sep; 18(9):1134-1140. PubMed ID: 23834035
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Implementation and Operational Research: Clinical Impact of the Xpert MTB/RIF Assay in Patients With Multidrug-Resistant Tuberculosis.
    Padayatchi N; Naidu N; Yende-Zuma N; OʼDonnell MR; Naidoo K; Augustine S; Zumla A; Loveday M
    J Acquir Immune Defic Syndr; 2016 Sep; 73(1):e1-7. PubMed ID: 27509173
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The New Xpert MTB/RIF Ultra: Improving Detection of
    Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
    Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
    Rachow A; Zumla A; Heinrich N; Rojas-Ponce G; Mtafya B; Reither K; Ntinginya EN; O'Grady J; Huggett J; Dheda K; Boehme C; Perkins M; Saathoff E; Hoelscher M
    PLoS One; 2011; 6(6):e20458. PubMed ID: 21738575
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa's Eastern Cape Province.
    Iruedo J; O'Mahony D; Mabunda S; Wright G; Cawe B
    BMC Infect Dis; 2017 Jan; 17(1):91. PubMed ID: 28109255
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cost-effectiveness of active case-finding of household contacts of pulmonary tuberculosis patients in a low HIV, tuberculosis-endemic urban area of Lima, Peru.
    Shah L; Rojas M; Mori O; Zamudio C; Kaufman JS; Otero L; Gotuzzo E; Seas C; Brewer TF
    Epidemiol Infect; 2017 Apr; 145(6):1107-1117. PubMed ID: 28162099
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Upfront Xpert MTB/RIF for diagnosis of pediatric TB-Does it work? Experience from India.
    Kalra A; Parija D; Raizada N; Sachdeva KS; Rao R; Swaminathan S; Khanna A; Chopra KK; Hanif M; Singh V; Umadevi KR; Sheladia KN; Rao R; Vasundhara N; S A; A R N; Azeem A; Chhajlani V; Khurana J; Das NJ; Choudhury B; Nair SA; Mall S; Sen R; Chadha SS; Denkinger CM; Boehme C; Sarin S
    PLoS One; 2020; 15(8):e0236057. PubMed ID: 32756559
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
    PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of Xpert MTB/RIF rollout on management of tuberculosis in a South African community.
    Schmidt BM; Geldenhuys H; Tameris M; Luabeya A; Mulenga H; Bunyasi E; Scriba T; Hatherill M
    S Afr Med J; 2017 Nov; 107(12):1078-1081. PubMed ID: 29262960
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained Settings.
    Muyoyeta M; Moyo M; Kasese N; Ndhlovu M; Milimo D; Mwanza W; Kapata N; Schaap A; Godfrey Faussett P; Ayles H
    PLoS One; 2015; 10(6):e0126376. PubMed ID: 26030301
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Active Case Finding for Tuberculosis in India: A Syntheses of Activities and Outcomes Reported by the National Tuberculosis Elimination Programme.
    Burugina Nagaraja S; Thekkur P; Satyanarayana S; Tharyan P; Sagili KD; Tonsing J; Rao R; Sachdeva KS
    Trop Med Infect Dis; 2021 Nov; 6(4):. PubMed ID: 34941662
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Extending 'Contact Tracing' into the Community within a 50-Metre Radius of an Index Tuberculosis Patient Using Xpert MTB/RIF in Urban, Pakistan: Did It Increase Case Detection?
    Fatima R; Qadeer E; Yaqoob A; Haq MU; Majumdar SS; Shewade HD; Stevens R; Creswell J; Mahmood N; Kumar AM
    PLoS One; 2016; 11(11):e0165813. PubMed ID: 27898665
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique.
    Floridia M; Ciccacci F; Andreotti M; Hassane A; Sidumo Z; Magid NA; Sotomane H; David M; Mutemba E; Cebola J; Mugunhe RJ; Riccardi F; Marazzi MC; Giuliano M; Palombi L; Mancinelli S
    Clin Infect Dis; 2017 Nov; 65(11):1878-1883. PubMed ID: 29020319
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria.
    Agizew T; Boyd R; Mathebula U; Mathoma A; Basotli J; Serumola C; Pals S; Finlay A; Lekone P; Rankgoane-Pono G; Tlhakanelo T; Chihota V; Auld AF
    PLoS One; 2020; 15(6):e0234646. PubMed ID: 32530972
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population.
    Raizada N; Sachdeva KS; Swaminathan S; Kulsange S; Khaparde SD; Nair SA; Khanna A; Chopra KK; Hanif M; Sethi GR; Umadevi KR; Keshav Chander G; Saha B; Shah A; Parmar M; Ghediya M; Jaju J; Boehme C; Paramasivan CN
    PLoS One; 2015; 10(10):e0140375. PubMed ID: 26469691
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Early detection of tuberculosis through community-based active case finding in Cambodia.
    Eang MT; Satha P; Yadav RP; Morishita F; Nishikiori N; van-Maaren P; Weezenbeek CL
    BMC Public Health; 2012 Jun; 12():469. PubMed ID: 22720878
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
    Mavenyengwa RT; Shaduka E; Maposa I
    Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.